Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma

被引:66
|
作者
Chen, Jingbiao [1 ]
Zhou, Jing [2 ]
Kuang, Sichi [1 ]
Zhang, Yao [1 ]
Xie, Sidong [1 ]
He, Bingjun [1 ]
Deng, Ying [1 ]
Yang, Hao [1 ]
Shan, Qungang [1 ]
Wu, Jun [1 ]
Sirlin, Claude B. [3 ]
Wang, Jin [1 ]
机构
[1] Sun Yat Sen Univ, Dept Radiol, Affiliated Hosp 3, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Dept Pathol, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China
[3] Univ Calif San Diego, Dept Radiol, Liver Imaging Grp, San Diego, CA 92103 USA
基金
中国国家自然科学基金;
关键词
hepatocellular carcinoma; Liver Imaging Reporting and Data System; microvascular invasion; MRI; recurrence; PREOPERATIVE PREDICTION;
D O I
10.2214/AJR.19.21168
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. We investigated in Liver Imaging Reporting and Data System category 5 (LR-5) observations whether imaging features, including LI-RADS imaging features, could predict microvascular invasion (MVI) and posthepatectomy recurrence in high-risk adult patients with hepatocellular carcinoma (HCC). MATERIALS AND METHODS. We retrospectively identified 149 high-risk patients who underwent 3-T MRI within 1 month before hepatectomy for HCC; 81 of 149 patients with no HCC recurrence were followed for more than 1 year. Tumors with clear surgical margins were confirmed in each hepatectomy specimen. MVI was evaluated histologically by a histopathologist. Tumor recurrence was determined by clinical and imaging follow-up. Two independent radiologists reviewed the prehepatectomy MR images and assessed LI-RADS v2018 imaging features as well as some non-LI-RADS features in all LR-5 observations in consensus. Alpha-fetoprotein level, tumor number, and imaging features were analyzed as potential predictors for MVI and posthepatectomy recurrence using multivariate logistic regression and Cox proportional hazards models. RESULTS. One hundred forty-nine patients with pathologically confirmed HCC were included; 64 of 149 (43.0%) patients had MVI, whereas 48 of 129 (37.2%) patients had tumor recurrence within 3 years after hepatectomy. Mosaic architecture (odds ratio, 3.420; p < 0.001) and nonsmooth tumor margin (odds ratio, 2.554; p = 0.011) were independent predictors of MVI. Multifocal tumors (hazard ratio, 2.101; p = 0.034), absence of fat in mass (hazard ratio, 2.109; p = 0.015), and nonsmooth tumor margin (hazard ratio, 2.415; p = 0.005) were independent predictors of posthepatectomy recurrence. CONCLUSION. In high-risk patients with LR-5 HCC, mosaic architecture and nonsmooth tumor margin independently predicted MVI. Multifocal tumors, absence of fat in mass, and nonsmooth tumor margin independently predicted recurrence.
引用
收藏
页码:821 / 830
页数:10
相关论文
共 50 条
  • [21] Role of microvascular invasion in early recurrence of hepatocellular carcinoma after liver resection: A literature review
    Zhang, Zhi-Hong
    Jiang, Chuang
    Qiang, Ze-Yuan
    Zhou, Yi-Fan
    Ji, Jun
    Zeng, Yong
    Huang, Ji-Wei
    ASIAN JOURNAL OF SURGERY, 2024, 47 (05) : 2138 - 2143
  • [22] Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies
    Kim, Yeun-Yoon
    Lee, Sunyoung
    Shin, Jaeseung
    Son, Won Jeong
    Roh, Yun Ho
    Hwang, Jeong Ah
    Lee, Ji Eun
    EUROPEAN RADIOLOGY, 2022, 32 (10) : 6723 - 6729
  • [23] Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies
    Yeun-Yoon Kim
    Sunyoung Lee
    Jaeseung Shin
    Won Jeong Son
    Yun Ho Roh
    Jeong Ah Hwang
    Ji Eun Lee
    European Radiology, 2022, 32 : 6723 - 6729
  • [24] Survival analysis of sorafenib in hepatocellular carcinoma patients with microvascular invasion after hepatectomy
    Zhang, Z.
    Huang, Y.
    Zhou, Y.
    Yang, J.
    Hu, K.
    Wang, Z.
    ANNALS OF ONCOLOGY, 2018, 29
  • [25] Impact of the Liver Imaging Reporting and Data System on Research Studies of Diagnosing Hepatocellular Carcinoma Using MRI
    Ahn, Yura
    Choi, Sang Hyun
    Jang, Jong Keon
    Kim, So Yeon
    Shim, Ju Hyun
    Lee, Seung Soo
    Byun, Jae Ho
    KOREAN JOURNAL OF RADIOLOGY, 2022, 23 (05) : 529 - 538
  • [26] Model predicting the microvascular invasion and satellite lesions of hepatocellular carcinoma after hepatectomy
    Shen, Junyi
    Wen, Tianfu
    Chen, Weixia
    Lu, Changli
    Yan, Lvnan
    Yang, Jiayin
    ANZ JOURNAL OF SURGERY, 2018, 88 (11) : E761 - E766
  • [27] Natural history of liver imaging reporting and data system category 4 nodules in MRI
    Lauren M. B. Burke
    Keitaro Sofue
    Madavi Alagiyawanna
    Viragi Nilmini
    Andrew J. Muir
    Kingshuk R. Choudhury
    Richard C. Semelka
    Mustafa R. Bashir
    Abdominal Radiology, 2016, 41 : 1758 - 1766
  • [28] Natural history of liver imaging reporting and data system category 4 nodules in MRI
    Burke, Lauren M. B.
    Sofue, Keitaro
    Alagiyawanna, Madavi
    Nilmini, Viragi
    Muir, Andrew J.
    Choudhury, Kingshuk R.
    Semelka, Richard C.
    Bashir, Mustafa R.
    ABDOMINAL RADIOLOGY, 2016, 41 (09) : 1758 - 1766
  • [29] A Practical Risk Classification of Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular invasion after Hepatectomy: A Decision Tree Analysis
    Feng, Long-Hai
    Zhu, Yu-Yao
    Zhou, Jia-Min
    Wang, Miao
    Wang, Lei
    Xu, Wei-Qi
    Zhang, Ti
    Mao, An-Rong
    Cong, Wen-Ming
    Dong, Hui
    Wang, Lu
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (01) : 363 - 372
  • [30] A Practical Risk Classification of Early Recurrence in Hepatocellular Carcinoma Patients with Microvascular invasion after Hepatectomy: A Decision Tree Analysis
    Long-Hai Feng
    Yu-Yao Zhu
    Jia-Min Zhou
    Miao Wang
    Lei Wang
    Wei-Qi Xu
    Ti Zhang
    An-Rong Mao
    Wen-Ming Cong
    Hui Dong
    Lu Wang
    Annals of Surgical Oncology, 2023, 30 : 363 - 372